Financial/nonfinancial disclosures: The authors have reported to CHEST the following: S. B. M. declares personal fees from Merck and NeRRe Therapeutics and grant support from Merck , the Australian National Health and Medical Research Council , and the Australian Research Council . L. M. reports personal fees from Chiesi , GSK, Merck , NeRRe Therapeutics, and Shionogi Inc; grant support from Merck; and other support from AstraZeneca , Boehringer Ingelheim, and Chiesi . A. B. C. has received fees from Up to Date, is on the data safety monitoring board for a vaccine study (Glaxo), is an advisor for study design of an unlicensed product ( Merck ), and has received multiple peer reviewed competitive grants from the Australian National Health and Medical Research Council . B. K. R. has received consulting fees from Merck , Boehringer Ingelheim, GlycoMira, and Ionis and has research grants from the NIH and Cystic Fibrosis Foundation . None declared (S. E., K. H., A. R., R. S. I., D. C. B., P. G. G.).
Funding Information:
Author contributions: All authors participated in conceiving of the content to be covered in this article, writing specific sections of the first draft, and reading and editing and approving of the final draft that was prepared by L. M. and S. B. M. Financial/nonfinancial disclosures: The authors have reported to CHEST the following: S. B. M. declares personal fees from Merck and NeRRe Therapeutics and grant support from Merck, the Australian National Health and Medical Research Council, and the Australian Research Council. L. M. reports personal fees from Chiesi, GSK, Merck, NeRRe Therapeutics, and Shionogi Inc; grant support from Merck; and other support from AstraZeneca, Boehringer Ingelheim, and Chiesi. A. B. C. has received fees from Up to Date, is on the data safety monitoring board for a vaccine study (Glaxo), is an advisor for study design of an unlicensed product (Merck), and has received multiple peer reviewed competitive grants from the Australian National Health and Medical Research Council. B. K. R. has received consulting fees from Merck, Boehringer Ingelheim, GlycoMira, and Ionis and has research grants from the NIH and Cystic Fibrosis Foundation. None declared (S. E. K. H. A. R. R. S. I. D. C. B. P. G. G.). ∗CHEST Expert Cough Panel Collaborators: Kenneth W. Altman, MD, PhD (Geisinger Commonwealth School of Medicine, Danville, PA); Alan F. Barker, MD (Oregon Health & Science University, Portland, OR); Surinder S. Birring, MBChB, MD (Division of Asthma, Allergy and Lung Biology, King's College London, Denmark Hill, London, England); Fiona Blackhall, MD, PhD (Department of Medical Oncology, University of Manchester, Manchester, England); Donald C. Bolser, PhD (College of Veterinary Medicine, University of Florida, Gainesville, FL); Sidney S. Braman, MD, FCCP (Mount Sinai Hospital, New York, NY); Christopher Brightling, MBBS, PhD, FCCP (University of Leicester, Glenfield Hospital, Leicester, England); Anne B. Chang, MBBS, PhD, MPH (Royal Children's Hospital, Brisbane, QLD, Australia); Andréanne Coté, MD (Institut universitaire de cardiologie et de pneumologie de Québec, Quebec, QC, Canada); Peter Gibson, MBBS (Hunter Medical Research Institute, Newcastle, NSW, Australia); Ali A. El Solh, MD, MPH (University at Buffalo, State University of New York, Buffalo, NY); Patricio Escalante, MD, FCCP (Mayo Clinic, Rochester, MN); Stephen K. Field, MD (University of Calgary, Calgary, AB, Canada); Dina Fisher, MD (Respiratory Medicine, University of Calgary, Calgary, AB, Canada); Cynthia T. French, PhD, FCCP (UMass Memorial Medical Center, Worcester, MA); Cameron Grant, MBChB, PhD (University of Auckland, Auckland, New Zealand); Susan M. Harding, MD, FCCP (Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL); Anthony Harnden, MBChB (University of Oxford, Oxford, England); Adam T. Hill, MBChB, MD (Royal Infirmary and University of Edinburgh, Edinburgh, Scotland); Richard S. Irwin, MD, Master FCCP (UMass Memorial Medical Center, Worcester, MA); Peter J. Kahrilas, MD (Feinberg School of Medicine, Northwestern University, Chicago, IL); Joanne Kavanagh, MBChB (Division of Asthma, Allergy and Lung Biology, King's College London, Denmark Hill, London, England); Karina A. Keogh, MD (Mayo Clinic, Rochester, MN); Andrew P. Lane, MD (Johns Hopkins University School of Medicine, Baltimore, MD); J. Mark Madison, MD (UMass Memorial Medical Center, Worcester, MA); Mark A. Malesker, PharmD, FCCP (Creighton University School of Pharmacy and Health Professions, Omaha, NE); Stuart Mazzone, PhD, FCCP (University of Melbourne, Melbourne, VIC, Australia); Lorcan McGarvey, MD (The Queens University Belfast, Belfast, Northern Ireland); M. Hassan Murad, MD, MPH (Mayo Clinic, Rochester, MN); Mangala Narasimhan, DO, FCCP (Hofstra-Northwell Health, Manhasset, NY); Peter Newcombe, PhD (School of Psychology, University of Queensland, Brisbane, QLD, Australia); John Oppenheimer, MD (UMDNJ-Rutgers University, Livingston, NJ); Bruce Rubin, MEngr, MD, MBA (Virginia Commonwealth University, Richmond, VA); Richard J. Russell, MBBS (University of Leicester, Glenfield Hospital, Leicester, England); Jay H. Ryu, MD, FCCP (Mayo Clinic, Rochester, MN); Sonal Singh, MD, MPH (UMass Memorial Medical Center, Worcester, MA); Maeve P. Smith, MBChB, MD (University of Alberta, Edmonton, AB, Canada); Susan M. Tarlo, MBBS, FCCP (Toronto Western Hospital, Toronto, ON, Canada); and Anne E. Vertigan, PhD, MBA, BAppSc (SpPath) (John Hunter Hospital, Newcastle, NSW, Australia); Abd Moain Abu Dabrh, MBBCh, MS (Mayo Clinic, Jacksonville, FL), Vivek Iyer, MD, MPH Mayo Clinic, Rochester MN), Kefang Lai, MD, PhD (First Affiliated Hospital of Guangzhou Medical College, Guangzhou, China), Kaiser Lim, MD (Mayo Clinic, Rochester, MN). Other contributions: We thank Nancy Harger, MLS, an education and clinical services librarian, working in the University of Massachusetts Medical School Library in Worcester, MA, who undertook all the searches for each section in this article.